Charles E. Binkley, MD, Michael S. Politz, MA, and Brian P. Green, PhD
If the safe-and-effective standard for judging devices’ potential as therapy or enhancement is inadequate, one might wonder whether BCI regulation should be overseen by the FDA.
AMA J Ethics. 2021;23(9):E745-749. doi:
10.1001/amajethics.2021.745.
Dr Charles Binkley joins Ethics Talk to discuss his article, coauthored with Michael Politz and Dr Brian Green: "Who, If Not the FDA, Should Regulate Implantable Brain-Computer Interface Devices?"
Dr Jeff Sebo joins Ethics Talk to discuss his article, coauthored with Zoe Griffiths: "How Should We Improve How Medical and Veterinary Students Learn About Human and Nonhuman Animals?"
Jessica Pierce, PhD, Marc Bekoff, PhD, Hope Ferdowsian, MD, MPH, Barbara J. King, PhD, and L. Syd M. Johnson, PhD
Our letter objects to the inclusion, in the April issue, of "Answers to Patient, Student, and Clinician Questions About How Animals Are Slaughtered and Used for Food," by Temple Grandin.
AMA J Ethics. 2023;25(6):E461-463. doi:
10.1001/amajethics.2023.461.
Joelle I. Rosser, MD, MS, Orion X. Lavery, Rebecca C. Christofferson, PhD, MApSt, Juma Nasoro, Francis M. Mutuku, PhD, and A. Desiree LaBeaud, MD, MS
Organizations’ architecture and communities’ waste stream designs situate how well industrial hygiene practices support or undermine individuals’ and communities’ pathogenic vulnerability.
AMA J Ethics. 2024;26(2):E132-141. doi:
10.1001/amajethics.2024.132.